Advanced search
Publication Cover
Leukemia & Lymphoma Volume 50, 2009 - Issue 3
Submit an article Journal homepage
121
Views
8
CrossRef citations to date
0
Altmetric
Letters to the Editor

Occurrence of t(15;17)(q22;q21) and t(9;22)(q34;q11) in a patient with acute promyelocytic leukemia

Liping Mao Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, People's Republic of China; Institute of Hematology, Zhejiang University, Hangzhou, Zhejiang, People's Republic of China
,
Huafeng Wang Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, People's Republic of China; Institute of Hematology, Zhejiang University, Hangzhou, Zhejiang, People's Republic of China
,
Yizhi Cheng Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, People's Republic of China; Institute of Hematology, Zhejiang University, Hangzhou, Zhejiang, People's Republic of China
,
Yungui Wang Institute of Hematology, Zhejiang University, Hangzhou, Zhejiang, People's Republic of China; Key Laboratory of Combined Multi-Organ Transplantation, Ministry of Public Health, Hangzhou, Zhejiang, People's Republic of China
,
Zhimei Chen Institute of Hematology, Zhejiang University, Hangzhou, Zhejiang, People's Republic of China; Key Laboratory of Combined Multi-Organ Transplantation, Ministry of Public Health, Hangzhou, Zhejiang, People's Republic of China
&
Dr. Professor Jin Jie Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, People's Republic of China; Institute of Hematology, Zhejiang University, Hangzhou, Zhejiang, People's Republic of China; Key Laboratory of Combined Multi-Organ Transplantation, Ministry of Public Health, Hangzhou, Zhejiang, People's Republic of ChinaCorrespondence[email protected]
Pages 466-470 | Received 14 Nov 2008, Accepted 08 Dec 2008, Published online: 01 Jul 2009

References

  • Sucić M, Zadro R, Burazer B, Labar B, Nemet D, Mrsić M, et al. Acute promyelocytic leukemia M3: cytomorphologic, immunophenotypic, cytogenetic, and molecular variants. J Hematother Stem Cell Res 2002; 11: 941–950
  • Grimwade D, Biondi A, Mozziconacci M J, Hagemeijer A, Berger R, Neat M, et al. Groupe Français de Cytogénétique Hématologique, Groupe Français d'Hématologie Cellulaire and UK cancer cytogenetics group and BIOMED 1 European community-concerted action “Molecular cytogenetic diagnosis in haematological malignancies.”, characterisation of acute promyelocytic leukemia cases lacking the classic t(15;17): results of the European working party. Blood 2000; 96: 1297–1308
  • García-Casado Z, Cervera J, Valencia A, Pajuelo J C, Mena-Duran A V, Barragán E, et al. t(17;20)(q21;q12) masking a variant t(15;17)(q22;q21) in a patient with acute promyelocytic leukemia. Cancer Genet Cytogenet 2006; 168: 73–76
  • Abe S, Ishikawa I, Harigae H, Sugawara T. A new complex translocation t(5;17;15)(q11;q21;q22) in acute promyelocytic leukemia. Cancer Genet Cytogenet 2008; 184: 44–47
  • Melo J V, Barnes D J. Chronic myeloid leukaemia as a model of disease evolution in human cancer. Nat Rev Cancer 2007; 7: 441–453
  • Mancini M, Scappaticci D, Cimino G, Nanni M, Derme V, Elia L, et al. A comprehensive genetic classification of adult acute lymphoblastic leukemia (ALL): analysis of the GIMEMA 0496 protocol. Blood 2005; 105: 3434–3441
  • ISCN. An International System for Human Cytogenetic Nomenclature. F Mitelman. S. Karger, Basel, Switzerland 2005
  • Wiernik P H, Dutcher J P, Paietta E, Hittelman W N, Vyas R, Strack M, et al. Treatment of promyelocytic blast crisis of chronic myelogenous leukemia with all trans-retinoic acid. Leukemia 1991; 5: 504–509
  • Kadam P R, Merchant A A, Advani S H. Cytogenetic findings in patients with acute promyelocytic leukemia and a case of CML blast crisis with promyelocytic proliferation. Cancer Genet Cytogenet 1990; 50: 109–117
  • Scolnik M P, Palacios M F, Acevedo S H, Castuma M V, Larripa I B, Palumbo A, et al. Promyelocytic blast crisis of chronic myelogenous leukaemia with translocations (9;22) and (15;17). Leuk Lymphoma 1998; 31: 231–236
  • Grimwade D, Solomon E. Characterisation of the PML/RAR α rearrangement associated with t(15;17) acute promyelocytic leukaemia. Curr Top Microbiol Immunol 1997; 220: 81–112
  • Park J P, Fairweather R B. Complex t(1;15;17) in acute promyelocytic leukemia with duplication of RARa and PML sequences. Cancer Genet Cytogenet 1996; 89: 52–56
  • Casula L, Archidiacono N, Grazia Pau M, Addis M, Mura R, Galanello R, et al. Cytogenetic and molecular characterization of a variant translocation associated with acute promyelocytic leukemia and involving chromosomes 11, 15 and 17. Leukemia 1996; 10: 1655–1657
  • Fujishima M, Takahashi N, Miura I, Kobayashi Y, Kume M, Nishinari T, et al. A PML/RARA chimeric gene on chromosome 2 in a patient with acute promyelocytic leukemia (M3) associated with a new variant translocation: t(2;15;17)(q21;q22;q21). Cancer Genet Cytogenet 2000; 120: 80–82
  • Liu S, Li Q, Pang W, Bo L, Qin S, Liu X, et al. A new complex variant t(4;15;17) in acute promyelocytic leukemia: fluorescence in situ hybridization confirmation and literature review. Cancer Genet Cytogenet 2001; 130: 33–37
  • Eclache V, Viguie F, Frocrain C, Cassinat B, Chomienne C, Cymbalista F, et al. A new variant t(6;15;17)(q25;q22;q21) in acute promyelocytic leukemia: fluorescence in situ hybridization confirmation. Cancer Genet Cytogenet 2005; 159: 69–73
  • Abea S, Ishikawab I, Harigaea H, Sugawarab T. A new complex translocation t(5;17;15)(q11;q21;q22) in acute promyelocytic leukemia. Cancer Genet Cytogenet 2008; 184: 44–47
  • Lo-Coco F, Ammatuna E, Montesinos P, Sanz M A. Acute promyelocytic leukemia: recent advances in diagnosis and management. Semin Oncol 2008; 35: 401–409
  • Rowley J D. Letter: a new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 1973; 243: 290–293
  • Kurzrock R, Gutterman J U, Talpaz M. The molecular genetics of Philadelphia chromosome-positive leukemias. N Engl J Med 1988; 319: 990–998
  • van der Kuip H, Moehring A, Wohlbold L, Miething C, Duyster J, Aulitzky W E. Imatinib mesylate (STI571) prevents the mutator phenotype of Bcr-Abl in hematopoietic cell lines. Leuk Res 2004; 28: 405–408
  • Buchdunger E, Zimmermann J, Mett H, Meyer T, Müller M, Druker B J, et al. Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative. Cancer Res 1996; 56: 100–104

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.